Amgen, actress Maura Tierney launch ‘Chemotherapy: Myths or Facts’ campaign

Monday, June 25, 2012 03:30 PM

Amgen, a biotech based in Thousand Oaks, Calif., has launched Chemotherapy: Myths or Facts, an awareness campaign for cancer patients and their caregivers featuring Emmy-nominated actress and breast cancer survivor Maura Tierney.

The campaign aims to debunk common misconceptions associated with chemotherapy and encourages patients and caregivers to take charge of their cancer journey by speaking openly with their doctors.

In 2009, Tierney was diagnosed with and treated for an aggressive form of breast cancer. Almost three years after successfully completing treatment, she now reflects on her cancer journey and its impact on her life with the hope of helping others.

"When I was going through my cancer treatment, I learned that you can never ask a stupid question. I asked every single question that came to my mind, and I believe that helped to calm my own anxiety," said Tierney. "The Chemotherapy: Myths or Facts campaign encourages patients and caregivers to ask a lot of questions, arming themselves with as much information as possible to take charge of their journey."

With approximately 650,000 patients undergoing chemotherapy in the U.S. each year, many people may think they already know how the disease and treatment will impact them or their loved one. However, chemotherapy can affect each patient's body differently, so it is important for patients to speak openly with their doctor to fully understand their treatment and what to expect.

"One common myth is that all patients receiving chemotherapy should avoid spending time with friends and family during their treatment," said Patrick Cobb, M.D., oncologist, Frontier Cancer Center, Billings, Mont. "This is largely untrue. While most people receiving chemotherapy should be careful about visiting others who are sick and avoid large crowds, having a support system in place to help keep a positive outlook is critical to a patient's emotional well-being during this time."

As part of the campaign, a video booth will travel across the country to collect personal stories of patients and caregivers to capture myths or facts they may have uncovered during their experience. More information on the booth, including what cities it will visit, and the campaign can be found at the campaign's website.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs